kmts: the income statement

MyFinsight

For the quarter ending 2025-07-31.

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

Income Statement	2025-07-31
Net loss attributable to kestra medical technologies, ltd	-25,826
Net loss attributable to common shareholders, diluted	-25,826

Earnings per share, basic	-0.5
Earnings per share, diluted	-0.5
Weighted average number of shares outstanding, basic	51,304,599
Weighted average number of shares outstanding, diluted	51,304,599

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

For the quarter ending 2025-07-31.

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

Income Statement	2025-07-31
Net loss attributable to kestra medical technologies, ltd	-25,826
Net loss attributable to common shareholders, diluted	-25,826

Earnings per share, basic	-0.5
Earnings per share, diluted	-0.5
Weighted average number of shares outstanding, basic	51,304,599
Weighted average number of shares outstanding, diluted	51,304,599